Biohaven Ltd. (BHVN)
NYSE · Manufacturing · Pharmaceutical preparations
$12.99−$0.2000 (−1.52%) on the dayAs of the close; data may be delayed.
BHVN price, last 12 months
Key stats
- Previous close
- $13.19
- Open
- $13.25
- Day range
- $12.77 – $13.35
- 52-week range
- $7.48 – $18.57
- Volume
- 1.6M
- Avg volume (20 days)
- 3.2M
- Market cap
- $2.0B
Performance
1W−4.6%
1M−23.4%
3M−17.9%
6M+45.6%
YTD+15.1%
1Y−5.5%
vs S&P 500, 1Y−22.2 pts
Technicals and fundamentals
About Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE
- Market cap
- $2.0B